🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a global, multicenter, randomized, open-label, Phase 2/3 study of D...
Status
Recruiting
Location
Research Site
Start Date
2025-09-26
Trial ID
NCT07129993
Treatments Being Tested
TROPION-Lung17 will measure the efficacy and safety of datopotamab deruxtec...
Status
Recruiting
Location
Research Site
Start Date
2025-10-31
Trial ID
NCT07291037
Treatments Being Tested
TROPION-DM/BrUOG-431 is a prospective, , phase 2 trial with two non-compara...
Status
Recruiting
Location
Rhode Island and the Miriam Hospitals (Brown University Health)
Start Date
2025-10-22
Trial ID
NCT06974604
Treatments Being Tested
This study is designed to determine the efficacy and safety of durvalumab i...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-12-21
Trial ID
NCT03742102
Treatments Being Tested
The study is intended to assess the safety and efficacy of perioperative tr...
Status
Recruiting
Location
Research Site
Start Date
2022-04-14
Trial ID
NCT05061550
This study will evaluate the efficacy, safety, and pharmacokinetics of DS-1...
Status
Active Not Recruiting
Location
Ironwood Cancer and Research Center
Start Date
2020-12-21
Trial ID
NCT04656652
Choice Of the Most Active Strategies for Short term recurring Triple Negati...
Status
Recruiting
Location
Gustave Roussy
Start Date
2024-07-05
Trial ID
NCT06508216
Treatments Being Tested
This is a Phase III, randomized, open-label, 3-arm, multicenter, internatio...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-11-28
Trial ID
NCT05629585
Treatments Being Tested
This is a Phase II, interventional, prospective, single-arm, multi-center s...
Status
Recruiting
Location
UNC Lineberger Comprehensive Cancer Center
Start Date
2026-02-26
Trial ID
NCT07069595
Treatments Being Tested
This is a Phase III, randomised, open-label, 2 arm, multicentre, internatio...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-05-16
Trial ID
NCT05374512
Treatments Being Tested